Anticoagulation and Antiplatelet Management During Perioperative Period
NCT ID: NCT03871283
Last Updated: 2020-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2400 participants
OBSERVATIONAL
2019-01-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Do Anesthesiologists Follow Belgian KCE Guidelines for Preoperative Evaluation?
NCT05805124
Perioperative Longitudinal Study of Complications and Long-term Outcomes
NCT05331118
Optimized Anesthesia to Reduce Postoperative Cognitive Impairment in the Elderly
NCT02698982
Improvement of Perioperative Care of Elderly Patients
NCT03325413
Longitudinal Cohort Study - for the Treatment of Acute Postoperative Pain and Postoperative Delirium, Postoperative Cognitive Dysfunctions, and Chronic Pain.
NCT03133858
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
the investigators want to investigate these transitions: how were they understood by patients, how were they performed, and how does this affect surgery, postoperative morbidity and mortality?
Anticoagulation for prevention of thromboembolic events will not be studied in this study.
The anesthesia team will not be particularly trained in anticoagulants and antiplatelets management to be close to actual care. In the Hospital the investigators have a guide written in 2013 in order to describe all the cases possible. The "control/ goal group" will be the patients who have undertaken strictly the protocol described for their cases in the guide.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to consent
* Taking anticoagulants or antiplatelet drugs in the long term.
Exclusion Criteria
* Minor patients
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Erasme University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivier DURANTEAU, Resident
Role: PRINCIPAL_INVESTIGATOR
ERASME UH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ERASME Hospital
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OMAHA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.